Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial

Clinical Trial ID NCT00941655

Rank	Title	Journal	Year	PubWeight™‹?›
1	The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.	J Natl Cancer Inst	1993	38.99
2	Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.	Eur J Cancer	2004	1.70
3	Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients.	Surgery	2003	1.67
4	Pulmonary resection for metastatic gastric cancer.	J Thorac Oncol	2010	1.51
5	Trial watch: Chemotherapy with immunogenic cell death inducers.	Oncoimmunology	2012	1.33
6	Liver resections in metastatic gastric cancer.	HPB (Oxford)	2010	1.00
7	The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone.	Trials	2009	0.91
8	Survival benefit of gastrectomy for gastric cancer with peritoneal carcinomatosis: a propensity score-matched analysis.	Cancer Med	2016	0.76